Anna M. Wu
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 0.5%
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 76
- Radiopharmaceutical Chemistry and Applications 73
- Oncology 60
- CAR-T cell therapy research 22
- Cancer Immunotherapy and Biomarkers 13
- HER2/EGFR in Cancer Research 12
- Co-authors
- Sanjiv S. Gambhir (13 shared papers)Gobalakrishnan Sundaresan (5 shared papers)Shimon Weiss (4 shared papers)Laurent A. Bentolila (4 shared papers)Sören Doose (1 shared paper)Xavier Michalet (1 shared paper)Fabien Pinaud (1 shared paper)James M. Tsay (1 shared paper)
- Journals
- Journal of Nuclear Medicine (13 papers)Molecular Imaging and Biology (11 papers)Protein Engineering Design and Selection (9 papers)Cancer Biotherapy and Radiopharmaceuticals (9 papers)Proceedings of the National Academy of Sciences (8 papers)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Anna M. Wu
216 papers receiving 17.4k citations
Anna M. Wu's Hit Papers
Peers
Comparison fields: 5 of 163
- Radiology, Nuclear Medicine and Imaging 4.9k
- Oncology 3.2k
- Materials Chemistry 5.0k
- Molecular Biology 6.7k
- Biomedical Engineering 3.7k
Countries citing papers authored by Anna M. Wu
This map shows the geographic impact of Anna M. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Wu more than expected).
Fields of papers citing papers by Anna M. Wu
This network shows the impact of papers produced by Anna M. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Wu. The network helps show where Anna M. Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna M. Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics Hit paper breakdown → | 2005 | 6389 |
| 2 | Arming antibodies: prospects and challenges for immunoconjugates Hit paper breakdown → | 2005 | 826 |
| 3 | Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression Hit paper breakdown → | 2017 | 401 |
| 4 | 1991 | 324 | |
| 5 | 1981 | 299 | |
| 6 | Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. | 1996 | 274 |
| 7 | 2015 | 237 | |
| 8 | 2007 | 226 | |
| 9 | 2006 | 192 | |
| 10 | 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. | 2003 | 180 |
| 11 | 2010 | 171 | |
| 12 | 2000 | 169 | |
| 13 | 1996 | 169 | |
| 14 | 2015 | 164 | |
| 15 | 2007 | 161 | |
| 16 | 2011 | 161 | |
| 17 | 2005 | 160 | |
| 18 | Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. | 2003 | 154 |
| 19 | 2008 | 149 | |
| 20 | 1986 | 148 |
About Anna M. Wu
Anna M. Wu is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Biomedical Engineering and Immunology, having authored 219 papers that have together received 17.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (76 papers), Radiopharmaceutical Chemistry and Applications (73 papers), CAR-T cell therapy research (22 papers), Glycosylation and Glycoproteins Research (14 papers), Lymphoma Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), HER2/EGFR in Cancer Research (12 papers) and Protein purification and stability (12 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (4.9k citations), Oncology (3.2k citations), Materials Chemistry (5.0k citations), Molecular Biology (6.7k citations) and Biomedical Engineering (3.7k citations). Anna M. Wu has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Sanjiv S. Gambhir, Gobalakrishnan Sundaresan, Shimon Weiss, Laurent A. Bentolila, Sören Doose, Xavier Michalet, Fabien Pinaud, James M. Tsay, Peter D. Senter and Tove Olafsen. Their work appears in journals such as Journal of Nuclear Medicine, Molecular Imaging and Biology, Protein Engineering Design and Selection, Cancer Biotherapy and Radiopharmaceuticals and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.